Dutch enforcer closes abuse probe into Pfizer
Pfizer has agreed to stop its exclusivity-based discount system for the provision of a drug supplied to hospitals for treating autoimmune diseases in order to end an abuse of dominance investigation by the Dutch competition authority.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.